Standard Biotools (LAB) Other Operating Expenses (2010 - 2026)

Standard Biotools (LAB) has 17 years of Other Operating Expenses data on file, last reported at $3.1 million in Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $3.1 million, up 98.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.3 million (up 113.93% YoY), and the FY2025 annual result was $14.8 million, up 108.76% from the prior year.
• Other Operating Expenses improved to $3.1 million in Q1 2026 per LAB's latest filing, from $2.1 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $14.3 million in Q1 2022 and troughed at -$57.7 million in Q2 2024.
• A 5-year average of -$19.9 million and a median of -$14.1 million in 2022 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2023 and 2025: Other Operating Expenses plunged 457922.22% in 2023, then surged 135.0% in 2025.
• A 5-year view of Other Operating Expenses shows it stood at -$1.2 million in 2022, then slumped by 4340.16% to -$55.3 million in 2023, then surged by 38.41% to -$34.0 million in 2024, then surged by 106.09% to $2.1 million in 2025, then soared by 48.43% to $3.1 million in 2026.
• Business Quant data shows LAB's Other Operating Expenses at $3.1 million in Q1 2026, $2.1 million in Q4 2025, and $9.4 million in Q3 2025.